PT  - JOURNAL ARTICLE
AU  - A.M. Burrows
AU  - W. Brinjikji
AU  - R.C. Puffer
AU  - H. Cloft
AU  - D.F. Kallmes
AU  - G. Lanzino
TI  - Flow Diversion for Ophthalmic Artery Aneurysms
AID  - 10.3174/ajnr.A4835
DP  - 2016 Oct 01
TA  - American Journal of Neuroradiology
PG  - 1866--1869
VI  - 37
IP  - 10
4099  - http://www.ajnr.org/content/37/10/1866.short
4100  - http://www.ajnr.org/content/37/10/1866.full
SO  - Am. J. Neuroradiol.2016 Oct 01; 37
AB  - SUMMARY: Endovascular treatments of ophthalmic segment aneurysms are commonly used but visual outcomes remain a concern. We performed a retrospective review of patients with carotid-ophthalmic aneurysms treated with flow diversion from June 2009 to June 2015. The following outcomes were studied through chart review: visual outcomes, complications, postoperative stroke and intraparenchymal hemorrhage, and clinical outcomes. Angiographic outcomes were studied with angiography and MRA at 6 months, 1 year, and 3 years. We evaluated 50 carotid-ophthalmic aneurysms in 48 patients, among whom 44 patients with 46 aneurysms underwent treatment. The mean clinical follow-up was 29 ± 22 months (range, 0–65 months). There were no permanent adverse visual outcomes. There was 1 death because of late intraparenchymal hemorrhage (2.2%). Six-month angiography showed complete occlusion in 24 of 37 patients (64.9%), and 3-year angiography results showed occlusion in 24 of 25 patients (96%). In conclusion, flow diversion is a safe and effective treatment for carotid-ophthalmic aneurysms in carefully selected patients. The risk of adverse visual outcomes is low, and most aneurysms progress to complete occlusion.PEDPipeline Embolization Device